Last reviewed · How we verify
Pro-miniCHOP-like regimen
Pro-miniCHOP-like regimen is a Small molecule drug developed by The First Affiliated Hospital of Soochow University. It is currently in Phase 1 development.
At a glance
| Generic name | Pro-miniCHOP-like regimen |
|---|---|
| Sponsor | The First Affiliated Hospital of Soochow University |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Pro-miniCHOP-like regimen CI brief — competitive landscape report
- Pro-miniCHOP-like regimen updates RSS · CI watch RSS
- The First Affiliated Hospital of Soochow University portfolio CI
Frequently asked questions about Pro-miniCHOP-like regimen
What is Pro-miniCHOP-like regimen?
Pro-miniCHOP-like regimen is a Small molecule drug developed by The First Affiliated Hospital of Soochow University.
Who makes Pro-miniCHOP-like regimen?
Pro-miniCHOP-like regimen is developed by The First Affiliated Hospital of Soochow University (see full The First Affiliated Hospital of Soochow University pipeline at /company/the-first-affiliated-hospital-of-soochow-university).
What development phase is Pro-miniCHOP-like regimen in?
Pro-miniCHOP-like regimen is in Phase 1.